StonvexLoading…
StonvexStonvexStonvexCore line items from HHS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $37.26M | $159.57M | $119.71M | $80.19M |
Operating Income | $-768.00K | $386.00K | $503.00K | $-6.00K |
Net Income | $-628.00K | $-811.00K | $-3.01M | $-335.00K |
EPS (Diluted) | $-0.08 | $-0.11 | $-0.41 | $-0.10 |
Total Assets | $90.41M | $91.83M | $92.71M | $95.02M |
Total Liabilities | $70.30M | $71.30M | $72.83M | $72.78M |
Cash & Equivalents | $4.53M | $5.58M | $6.51M | $4.76M |
Free Cash Flow OCF − CapEx | $-922.00K | $-4.49M | $-3.81M | $-6.00M |
Shares Outstanding | 7.42M | 7.41M | 7.41M | 7.41M |